Clinical and cost-effectiveness of Rosiglitazone-Metformin combination in patients with Type-2 Diabetes in Spain

被引：0
|
作者：
Shearer, A
Bagust, A
Ampudia-Blasco, J
Martinez-Lage, B
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A293 / A293
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness in Germany of rosiglitazone-metformin combination in Type 2 diabetes.
    Bagust, A
    Shearer, A
    Schoeffski, O
    Reitberger, U
    Goertz, A
    Behrens, M
    DIABETOLOGIA, 2003, 46 : A444 - A444
  • [2] Cost-effectiveness of rosiglitazone-metformin combination in overweight patients with type 2 diabetes in Germany
    Shearer, A
    Bagust, A
    Schoeffski, O
    Reitberger, U
    Goertz, A
    Behrens, M
    VALUE IN HEALTH, 2003, 6 (06) : 607 - 607
  • [3] Lifetime cost-effectiveness of rosiglitazone-metformin combination in obese patients with Type 2 diabetes in Germany
    Goertz, A
    Shearer, A
    Bagust, A
    Schoeffski, O
    Liebl, A
    DIABETOLOGIA, 2004, 47 : A356 - A356
  • [4] Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain
    Shearer A.T.
    Bagust A.
    Ampudia-Blasco F.J.
    Álvarez B.M.-L.
    Escolano I.P.
    París G.
    PharmacoEconomics, 2006, 24 (Suppl 1) : 49 - 59
  • [5] Lifetime cost-effectiveness of rosiglitazone/metformin fixed dose combination for the treatment of type 2 diabetes in Portugal
    Taylor, M.
    Shearer, A.
    Bagust, A.
    Vaz, J. P.
    Pereira, J.
    DIABETES, 2006, 55 : A548 - A548
  • [6] Rosiglitazone-metformin combination therapy improves glycemic control in Mexican patients with Type 2 diabetes
    Gomez-Perez, FJ
    Fanghanel-Salmon, G
    Berry, RA
    Warsi, G
    Gould, EM
    DIABETES, 2001, 50 : A436 - A436
  • [7] Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain
    Pinol, Carme
    Roze, Stephane
    Valentine, William
    Evers, Thomas
    GACETA SANITARIA, 2007, 21 (02) : 97 - 104
  • [8] Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany
    Shearer A.T.
    Bagust A.
    Liebl A.
    Schoeffski O.
    Goertz A.
    PharmacoEconomics, 2006, 24 (Suppl 1) : 35 - 48
  • [9] Clinical effectiveness of a combination of metformin and ipragliflozin in the management of patients with type-2 diabetes mellitus
    Tani, Xiaojie
    Sung, Guijuan
    Yuan, Fei
    Qu, Linfang
    Han, Aiqiang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (04) : 783 - 788
  • [10] Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK
    Sophie Beale
    Adrian Bagust
    Arran T. Shearer
    Alan Martin
    Lisa Hulme
    PharmacoEconomics, 2006, 24 (Suppl 1) : 21 - 34
12345